Okabayashi, T.; Sui, K.; Tabuchi, M.; Murokawa, T.; Sakamoto, S.; Iwata, J.; Morita, S.; Okamoto, N.; Iiyama, T.; Shimada, Y.;
et al. Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. J. Clin. Med. 2022, 11, 6792.
https://doi.org/10.3390/jcm11226792
AMA Style
Okabayashi T, Sui K, Tabuchi M, Murokawa T, Sakamoto S, Iwata J, Morita S, Okamoto N, Iiyama T, Shimada Y,
et al. Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. Journal of Clinical Medicine. 2022; 11(22):6792.
https://doi.org/10.3390/jcm11226792
Chicago/Turabian Style
Okabayashi, Takehiro, Kenta Sui, Motoyasu Tabuchi, Takahiro Murokawa, Shinichi Sakamoto, Jun Iwata, Sojiro Morita, Nobuto Okamoto, Tatsuo Iiyama, Yasuhiro Shimada,
and et al. 2022. "Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer" Journal of Clinical Medicine 11, no. 22: 6792.
https://doi.org/10.3390/jcm11226792
APA Style
Okabayashi, T., Sui, K., Tabuchi, M., Murokawa, T., Sakamoto, S., Iwata, J., Morita, S., Okamoto, N., Iiyama, T., Shimada, Y., & Fujiwara, T.
(2022). Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. Journal of Clinical Medicine, 11(22), 6792.
https://doi.org/10.3390/jcm11226792